| Foreword | 5 |
|---|
| Preface | 7 |
|---|
| Contents | 10 |
|---|
| Contributors | 12 |
|---|
| Color Plates | 17 |
|---|
| Chapter 1 Sexual Dysfunction After Radical Prostatectomy | 18 |
|---|
| 1.1 Introduction | 19 |
| 1.2 Erectile Dysfunction | 19 |
| 2.1 Defining Erectile Function Outcomes After Radical Prostatectomy | 20 |
| 2.2 Erectile Function Outcomes | 22 |
| 1.3 Anejaculation | 24 |
| 1.4 Orgasm Alterations | 25 |
| 1.5 Peyronies Disease | 27 |
| 1.6 Penile Length Alterations | 28 |
| 1.7 Summary | 30 |
| Chapter 2 The Impact of Prostate Cancer Diagnosis and Post-treatment Sexual Dysfunction on Quality of Life | 34 |
|---|
| 2.1 Assessing Quality of Life in Prostate Cancer Survivors | 34 |
| 2.2 The Effect of Prostate Cancer Diagnosis on Generic Quality of Life | 36 |
| 2.3 The Psychological Effect of a New Prostate Cancer Diagnosis | 38 |
| 2.4 The Effect of Post-treatment Sexual Dysfunction on Quality of Life | 40 |
| 2.5 The Psychological Effect of Post-treatment Sexual Dysfunction | 44 |
| 2.6 Conclusions | 45 |
| Chapter 3 Pathophysiology of Erectile Dysfunction Following Radical Prostatectomy | 50 |
|---|
| 3.1 Epidemiology of Prostate Cancer and Erectile Dysfunction | 51 |
| 3.2 Penile Anatomy and Physiology | 52 |
| 2.1 Morphology of the Penis | 52 |
| 2.2 Vascular Anatomy of the Penis | 52 |
| 2.3 Neural Innervation of the Penis | 54 |
| 3.3 Molecular Signaling of Erections | 54 |
| 3.1 NO/NOS | 55 |
| 3.1.1 Normal Signaling | 55 |
| 3.1.2 NO/NOS after RRP | 56 |
| 3.2 Smooth Muscle/Myosin--Actin/Calcium/Rho-Kinase | 57 |
| 3.3 SHH and the Penis | 59 |
| 3.4 Supporting Cast/Integration | 61 |
| 3.4 Long-Term ED | 62 |
| 4.1 Hypoxia | 62 |
| 4.2 Ultra-structural End Organ Changes and Long-Term ED | 63 |
| 3.5 Conclusions | 64 |
| Chapter 4 Pathophysiology of Erectile Dysfunction Following Radiation Therapy | 71 |
|---|
| 4.1 Introduction | 71 |
| 4.2 Normal Physiology | 72 |
| 4.3 Mechanisms of Injury After Prostate Irradiation | 74 |
| 3.1 Vasculogenic Mechanisms | 74 |
| 3.2 Neurogenic Mechanisms | 77 |
| 3.3 Structural Injury | 78 |
| 4.4 Conclusion | 80 |
| Chapter 5 Evolution of Radical Prostatectomy as It Pertains to Nerve-Sparing | 84 |
|---|
| 5.1 Introduction | 84 |
| 5.2 Anatomical Considerations | 85 |
| 5.3 Technique | 87 |
| 3.1 Initial Steps and Control of Bleeding | 87 |
| 3.2 Preservation of the Neurovascular Bundle (NVB) | 88 |
| 5.4 Erectile Function After Nerve-Sparing Radical Prostatectomy | 92 |
| 5.5 Strategies to Improve Sexual Function after Radical Prostatectomy | 94 |
| 5.1 Early Use of Intracavernosal Agents | 94 |
| 5.2 Early Use of Phosphodiesterase-5 Inhibitors | 95 |
| 5.3 Perioperative Immunophilin Ligand Therapy | 95 |
| Chapter 6 Laparoscopic and Robotic-Assisted Radical Prostatectomy: Sexual Function Outcome | 97 |
|---|
| 6.1 Introduction | 97 |
| 6.2 Heterogeneity of Results | 98 |
| 6.3 Sexual Function Outcome | 98 |
| Chapter 7 Potency-Sparing Radiation: Myth or Reality? | 104 |
|---|
| 7.1 Introduction | 105 |
| 7.2 Critical Endpoints | 105 |
| 7.3 Post-radiation Effects on Sexual Function Timing and Targets | 108 |
| 3.1 Biology, Timing, and Targets | 108 |
| 3.2 Radiation Reactions | 109 |
| 3.3 Clinical Syndromes | 111 |
| 7.4 Potential Target Definition | 111 |
| 4.1 Prostate Apex Definition | 112 |
| 4.2 Definition of Critical Erectile Structures (CES) | 113 |
| 4.3 Radiation Treatment Planning | 116 |
| 7.5 Potency-Sparing Radiotherapy Preliminary Results | 116 |
| 7.6 Summary | 118 |
| Chapter 8 Neuromodulatory Drugs for the Radical Prostatectomy Patient | 123 |
|---|
| 8.1 Introduction | 124 |
| 8.2 Pathogenesis of Acute, Traumatic Penile Neuropathy | 125 |
| 2.1 Peripheral Nerve Degeneration and Regeneration | 125 |
| 2.2 Cavernous Nerve Injury | 127 |
| 8.3 Therapeutic Penile Neurogenesis | 127 |
| 3.1 Preclinical Investigation | 128 |
| 3.2 Clinical Trials | 131 |
| 8.4 New Frontiers in Molecular Neurobiology | 132 |
| 4.1 Signal Transduction Mechanisms | 133 |
| 8.5 Special Considerations | 134 |
| 8.6 Conclusion | 135 |
| Chapter 9 Nerve Grafting at Radical Retropubic Prostatectomy: Rationale, Technique, and Results | 141 |
|---|
| 9.1 Introduction | 141 |
| 9.2 Fundamentals | 142 |
| 9.3 Indications | 143 |
| 9.4 Surgical Technique | 144 |
| 9.5 Results | 146 |
| 9.6 Conclusions | 148 |
| Chapter 10 Erectile Function Preservation and Rehabilitation | 151 |
|---|
| 10.1 Introduction | 152 |
| 10.2 Pathophysiology of Erectile Dysfunction After Radical Prostatectomy | 152 |
| 2.1 Neural Trauma | 153 |
| 2.2 Arteriogenic ED | 154 |
| 2.3 The Concept of Cavernosal Oxygenation | 158 |
| 2.4 Corporo-venoocclusive Dysfunction | 158 |
| 2.5 Psychogenic Mechanisms | 159 |
| 10.3 Penile Rehabilitation of the Erectile Function After Radical Prostatectomy | 159 |
| 3.1 Data Supporting the Concept of PDE5 Inhibitor Rehabilitation | 159 |
| 3.2 Endothelial Protection | 160 |
| 3.3 PDE5 Inhibitor-Induced Neurogenesis | 162 |
| 10.4 Cavernosal Smooth Muscle Protection | 162 |
| 4
|